6XG7 | pdb_00006xg7

1.3 A Resolution Structure of the of the NHL Repeat Region of D. melanogaster Thin


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.30 Å
  • R-Value Free: 
    0.174 (Depositor), 0.184 (DCC) 
  • R-Value Work: 
    0.138 (Depositor), 0.152 (DCC) 
  • R-Value Observed: 
    0.140 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6XG7

This is version 1.4 of the entry. See complete history

Literature

Costameric integrin and sarcoglycan protein levels are altered in a Drosophila model for Limb-girdle muscular dystrophy type 2H.

Bawa, S.Gameros, S.Baumann, K.Brooks, D.S.Kollhoff, J.A.Zolkiewski, M.Re Cecconi, A.D.Panini, N.Russo, M.Piccirillo, R.Johnson, D.K.Kashipathy, M.M.Battaile, K.P.Lovell, S.Bouyain, S.E.A.Kawakami, J.Geisbrecht, E.R.

(2021) Mol Biol Cell 32: 260-273

  • DOI: https://doi.org/10.1091/mbc.E20-07-0453
  • Primary Citation Related Structures: 
    6XG7

  • PubMed Abstract: 

    Mutations in two different domains of the ubiquitously expressed TRIM32 protein give rise to two clinically separate diseases, one of which is Limb-girdle muscular dystrophy type 2H (LGMD2H). Uncovering the muscle-specific role of TRIM32 in LGMD2H pathogenesis has proven difficult, as neurogenic phenotypes, independent of LGMD2H pathology, are present in TRIM32 KO mice. We previously established a platform to study LGMD2H pathogenesis using Drosophila melanogaster as a model. Here we show that LGMD2H disease-causing mutations in the NHL domain are molecularly and structurally conserved between fly and human TRIM32. Furthermore, transgenic expression of a subset of myopathic alleles (R394H, D487N, and 520fs) induce myofibril abnormalities, altered nuclear morphology, and reduced TRIM32 protein levels, mimicking phenotypes in patients afflicted with LGMD2H. Intriguingly, we also report for the first time that the protein levels of βPS integrin and sarcoglycan δ, both core components of costameres, are elevated in TRIM32 disease-causing alleles. Similarly, murine myoblasts overexpressing a catalytically inactive TRIM32 mutant aberrantly accumulate α- and β-dystroglycan and α-sarcoglycan. We speculate that the stoichiometric loss of costamere components disrupts costamere complexes to promote muscle degeneration.


  • Organizational Affiliation
    • Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506.

Macromolecule Content 

  • Total Structure Weight: 33.47 kDa 
  • Atom Count: 2,540 
  • Modeled Residue Count: 288 
  • Deposited Residue Count: 307 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Thin, isoform D307Drosophila melanogasterMutation(s): 0 
Gene Names: tnAbbaDmel\CG15105l(2)tnCG15105Dmel_CG15105
UniProt
Find proteins for B7YZK8 (Drosophila melanogaster)
Explore B7YZK8 
Go to UniProtKB:  B7YZK8
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupB7YZK8
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
CSO
Query on CSO
A
L-PEPTIDE LINKINGC3 H7 N O3 SCYS

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.30 Å
  • R-Value Free:  0.174 (Depositor), 0.184 (DCC) 
  • R-Value Work:  0.138 (Depositor), 0.152 (DCC) 
  • R-Value Observed: 0.140 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 42.633α = 90
b = 51.917β = 90
c = 105.119γ = 90
Software Package:
Software NamePurpose
XDSdata reduction
Aimlessdata scaling
PHASERphasing
PHENIXrefinement
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesP30 GM110761

Revision History  (Full details and data files)

  • Version 1.0: 2020-12-16
    Type: Initial release
  • Version 1.1: 2021-02-10
    Changes: Database references
  • Version 1.2: 2023-10-18
    Changes: Data collection, Database references, Refinement description
  • Version 1.3: 2023-11-15
    Changes: Data collection
  • Version 1.4: 2024-10-16
    Changes: Structure summary